ICS performs an in-depth financial analysis during the planning process for each of our manufacturer clients. For manufacturers who need to mitigate risk and realize revenue quickly and consistently, ICS offers a unique Title Model for streamlining AR processes and assuming financial ownership of the distribution process.
ICS Title Model addresses the concerns of manufacturers that:
Under our Title Model, the title ownership of a new drug is transferred to ICS. As the manufacturer, you hold the patent and control the sales, while ICS handles all other aspects of distribution, including orchestrating freight and quality control measures, facilitating compliance and licensing requirements, managing cold chain and special product handling needs and owning and supporting the accounts receivable relationships with downstream customer. The result? Streamlined speed to market that shrinks the critical time window between product development and product availability.